Bio-Rad Laboratories (BIO) Net Profit Margin: History & Chart

Bio-Rad Laboratories, Inc.(BIO)

Medical - Devices · Hercules, CA

$369.32+0.57 (+0.15%)

Delayed quote: Sep 11, 2026, 4:00 PM EDT

About Bio-Rad Laboratories, Inc.

Bio-Rad Laboratories, Inc., established in 1952 and headquartered in Hercules, California, operates as a global provider of life science research and clinical diagnostic products. Its operations span across the United States, Canada, Europe, Asia, and Latin America. The company is organized into two primary divisions: Life Science and Clinical Diagnostics. The Life Science division is responsible for developing, manufacturing, and commercializing a diverse array of reagents, equipment, and laboratory instruments. These products are crucial for various research methodologies, biopharmaceutical manufacturing processes, and food quality testing. This segment focuses on specialized areas within the life sciences, including proteomics, genomics, biopharmaceutical production, cellular biology, and food safety. Its clientele encompasses academic institutions (such as universities and medical schools), industrial research organizations, government agencies, pharmaceutical companies, biotechnology firms, food producers, and food testing laboratories. In contrast, the Clinical Diagnostics division designs, produces, sells, and supports a comprehensive suite of test systems, informatics solutions, diagnostic kits, and specialized quality control products for clinical laboratories. This segment provides reagents, instruments, and software specifically tailored for particular niches within the in vitro diagnostics market. Its customer base includes reference laboratories, hospital laboratories, state newborn screening facilities, physicians' office laboratories, and transfusion laboratories. Beyond these core segments, Bio-Rad also offers systems and products designed to separate complex chemical and biological materials, as well as to identify, analyze, and purify their individual components. The company distributes its extensive product portfolio through a combination of its direct sales force and a network of third-party distributors, agents, brokers, and resellers.

Hercules, CA

7,450 employees

www.bio-rad.com

Healthcare / Medical - Devices

Sector: Healthcare
Industry: Medical - Devices
CEO: Norman D. Schwartz

View full financials

BIO Net Profit Margin Metrics

NET PROFIT MARGIN

8.59%

NET PROFIT MARGIN AVG TTM

13.66%

NET PROFIT MARGIN AVG 3Y

2.74%

NET PROFIT MARGIN AVG 5Y

-22.49%

NET PROFIT MARGIN AVG 10Y

27.96%

NET PROFIT MARGIN AVG 15Y

30.37%

NET PROFIT MARGIN AVG 20Y

6.45%

CURRENT VS TTM AVG

-37.12%

CURRENT VS 3Y AVG

+213.40%

CURRENT VS 5Y AVG

+138.19%

CURRENT VS 10Y AVG

-69.28%

CURRENT VS 15Y AVG

-71.72%

CURRENT VS 20Y AVG

+33.11%

SECTOR MEDIAN · HEALTHCARE

9.21%

median of 90 covered companies

CURRENT VS SECTOR MEDIAN

-6.68%

vs the sector median at left

NAME	MARKET CAP	NET PROFIT MARGIN	TTM	3Y	5Y
Bio-Rad Laboratories, Inc. (BIO)	$9.94B	8.59%	13.66%	2.74%	-22.49%
Globus Medical, Inc. (GMED)vs ›	$10.01B	17.03%	11.20%	12.20%	12.89%
Henry Schein, Inc. (HSIC)vs ›	$10.07B	2.96%	3.05%	3.43%	3.79%
The Ensign Group, Inc. (ENSG)vs ›	$10.14B	6.90%	6.89%	6.71%	6.89%
Tempus AI, Inc. (TEM)vs ›	$10.34B	-17.77%	-60.53%	-62.93%	-77.31%
The Cooper Companies, Inc. (COO)vs ›	$10.51B	13.46%	9.62%	9.77%	24.94%
Universal Health Services, Inc. (UHS)vs ›	$10.58B	8.42%	7.89%	6.46%	6.98%
Molina Healthcare, Inc. (MOH)vs ›	$10.66B	-0.02%	1.97%	2.41%	2.58%
Insulet Corp. (PODD)vs ›	$9.14B	12.29%	14.66%	10.46%	7.35%
Align Technology, Inc. (ALGN)vs ›	$10.80B	9.99%	10.36%	10.48%	22.21%

NAME

MARKET CAP

NET PROFIT MARGIN

TTM

Bio-Rad Laboratories, Inc. (BIO)

$9.94B

8.59%

13.66%

2.74%

-22.49%

Globus Medical, Inc. (GMED)vs ›

$10.01B

17.03%

11.20%

12.20%

12.89%

Henry Schein, Inc. (HSIC)vs ›

$10.07B

2.96%

3.05%

3.43%

3.79%

The Ensign Group, Inc. (ENSG)vs ›

$10.14B

6.90%

6.89%

6.71%

6.89%

Tempus AI, Inc. (TEM)vs ›

$10.34B

-17.77%

-60.53%

-62.93%

-77.31%

The Cooper Companies, Inc. (COO)vs ›

$10.51B

13.46%

9.62%

9.77%

24.94%

Universal Health Services, Inc. (UHS)vs ›

$10.58B

8.42%

7.89%

6.46%

6.98%

Molina Healthcare, Inc. (MOH)vs ›

$10.66B

-0.02%

1.97%

2.41%

2.58%

Insulet Corp. (PODD)vs ›

$9.14B

12.29%

14.66%

10.46%

7.35%

Align Technology, Inc. (ALGN)vs ›

$10.80B

9.99%

10.36%

10.48%

22.21%

Net Profit Margin FAQ

What is the net profit margin for Bio-Rad Laboratories, Inc. (BIO)?

The net profit margin for BIO stock is 8.59%.

Is Bio-Rad Laboratories, Inc.'s net profit margin high or low?

The net profit margin of 8.59% is 138% above its 5-year average of -22.49%, around the middle of its 5-year range (-481.01%–525.81%).

What is the TTM average net profit margin for Bio-Rad Laboratories, Inc. (BIO)?

The TTM average net profit margin for BIO stock is 13.66%.

What is the 3Y average net profit margin for Bio-Rad Laboratories, Inc. (BIO)?

The 3Y average net profit margin for BIO stock is 2.74%.

What is the 5Y average net profit margin for Bio-Rad Laboratories, Inc. (BIO)?

The 5Y average net profit margin for BIO stock is -22.49%.

What is the 10Y average net profit margin for Bio-Rad Laboratories, Inc. (BIO)?

The 10Y average net profit margin for BIO stock is 27.96%.

What is the 15Y average net profit margin for Bio-Rad Laboratories, Inc. (BIO)?

The 15Y average net profit margin for BIO stock is 30.37%.

What is the 20Y average net profit margin for Bio-Rad Laboratories, Inc. (BIO)?

The 20Y average net profit margin for BIO stock is 6.45%.

DATE	NET PROFIT MARGIN
2026-06-30	57.05%
2026-03-31	-89.02%
2025-12-31	103.87%
2025-09-30	-52.36%
2025-06-30	48.77%
2025-03-31	10.93%
2024-12-31	-107.24%
2024-09-30	100.53%
2024-06-30	-339.16%
2024-03-31	62.85%
2023-12-31	51.34%
2023-09-30	16.81%
2023-06-30	-170.64%
2023-03-31	10.19%
2022-12-31	114.13%
2022-09-30	-24.12%
2022-06-30	-134.16%
2022-03-31	-481.01%
2021-12-31	-214.76%
2021-09-30	525.81%
2021-06-30	127.68%
2021-03-31	134.48%
2020-12-31	106.24%
2020-09-30	203.14%
2020-06-30	180.01%
2020-03-31	119.99%
2019-12-31	88.64%
2019-09-30	-46.16%
2019-06-30	104.57%
2019-03-31	156.18%
2018-12-31	-134.91%
2018-09-30	49.41%
2018-06-30	46.54%
2018-03-31	119.08%
2017-12-31	11.27%
2017-09-30	5.12%
2017-06-30	1.00%
2017-03-31	2.48%
2016-12-31	-3.60%
2016-09-30	3.62%
2016-06-30	3.49%
2016-03-31	2.61%
2015-12-31	8.67%
2015-09-30	3.70%
2015-06-30	5.62%
2015-03-31	3.77%
2014-12-31	6.53%
2014-09-30	2.17%
2014-06-30	5.89%
2014-03-31	1.31%
2013-12-31	5.00%
2013-09-30	-1.41%
2013-06-30	6.60%
2013-03-31	3.90%
2012-12-31	8.28%
2012-09-30	8.50%
2012-06-30	9.47%
2012-03-31	6.38%
2011-12-31	10.77%
2011-09-30	8.89%
2011-06-30	7.68%
2011-03-31	6.81%
2010-12-31	12.72%
2010-09-30	9.49%
2010-06-30	8.12%
2010-03-31	7.67%
2009-12-31	7.65%
2009-09-30	8.36%
2009-06-30	8.89%
2009-03-31	7.55%
2008-12-31	-1.83%
2008-09-30	6.30%
2008-06-30	9.59%
2008-03-31	6.28%
2007-12-31	2.69%
2007-09-30	8.23%
2007-06-30	7.57%
2007-03-31	8.37%
2006-12-31	4.85%
2006-09-30	7.60%
2006-06-30	10.15%
2006-03-31	10.12%
2005-12-31	4.38%
2005-09-30	5.73%
2005-06-30	6.31%
2005-03-31	11.20%
2004-12-31	5.56%
2004-09-30	2.43%
2004-06-30	8.78%
2004-03-31	8.24%
2003-12-31	7.21%
2003-09-30	3.90%
2003-06-30	8.61%
2003-03-31	10.72%
2002-12-31	6.68%
2002-09-30	7.39%

DATE

NET PROFIT MARGIN

2026-06-30

57.05%

2026-03-31

-89.02%

2025-12-31

103.87%

2025-09-30

-52.36%

2025-06-30

48.77%

2025-03-31

10.93%

2024-12-31

-107.24%

2024-09-30

100.53%

2024-06-30

-339.16%

2024-03-31

62.85%

2023-12-31

51.34%

2023-09-30

16.81%

2023-06-30

-170.64%

2023-03-31

10.19%

2022-12-31

114.13%

2022-09-30

-24.12%

2022-06-30

-134.16%

2022-03-31

-481.01%

2021-12-31

-214.76%

2021-09-30

525.81%

2021-06-30

127.68%

2021-03-31

134.48%

2020-12-31

106.24%

2020-09-30

203.14%

2020-06-30

180.01%

2020-03-31

119.99%

2019-12-31

88.64%

2019-09-30

-46.16%

2019-06-30

104.57%

2019-03-31

156.18%

2018-12-31

-134.91%

2018-09-30

49.41%

2018-06-30

46.54%

2018-03-31

119.08%

2017-12-31

11.27%

2017-09-30

5.12%

2017-06-30

1.00%

2017-03-31

2.48%

2016-12-31

-3.60%

2016-09-30

3.62%

2016-06-30

3.49%

2016-03-31

2.61%

2015-12-31

8.67%

2015-09-30

3.70%

2015-06-30

5.62%

2015-03-31

3.77%

2014-12-31

6.53%

2014-09-30

2.17%

2014-06-30

5.89%

2014-03-31

1.31%

2013-12-31

5.00%

2013-09-30

-1.41%

2013-06-30

6.60%

2013-03-31

3.90%

2012-12-31

8.28%

2012-09-30

8.50%

2012-06-30

9.47%

2012-03-31

6.38%

2011-12-31

10.77%

2011-09-30

8.89%

2011-06-30

7.68%

2011-03-31

6.81%

2010-12-31

12.72%

2010-09-30

9.49%

2010-06-30

8.12%

2010-03-31

7.67%

2009-12-31

7.65%

2009-09-30

8.36%

2009-06-30

8.89%

2009-03-31

7.55%

2008-12-31

-1.83%

2008-09-30

6.30%

2008-06-30

9.59%

2008-03-31

6.28%

2007-12-31

2.69%

2007-09-30

8.23%

2007-06-30

7.57%

2007-03-31

8.37%

2006-12-31

4.85%

2006-09-30

7.60%

2006-06-30

10.15%

2006-03-31

10.12%

2005-12-31

4.38%

2005-09-30

5.73%

2005-06-30

6.31%

2005-03-31

11.20%

2004-12-31

5.56%

2004-09-30

2.43%

2004-06-30

8.78%

2004-03-31

8.24%

2003-12-31

7.21%

2003-09-30

3.90%

2003-06-30

8.61%

2003-03-31

10.72%

2002-12-31

6.68%

2002-09-30

7.39%

Net Profit Margin: 8.59%

BIO Profit Margin

BIO Average Net Profit Margin Chart

BIO Current vs Average Net Profit Margin Chart

BIO Net Profit Margin Metrics

BIO Competitors' Net Profit Margin

Margin Comparison

Net Profit Margin Formula & Definition

Net Profit Margin FAQ

BIO Net Profit Margin History

Related Metrics